|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| C07K 16/2818 | (2013.01) | ||
| A61K 31/4745 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61K 31/708 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 31/4375 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61K 47/50 | (2017.01) | ||
| A61K 47/6851 | (2017.08) | ||
| A61K 45/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3763742 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20191420.7 |
| Date of filing the European patent application | 2015-08-29 | |
| (97) | Date of publication of the European application | 2021-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201410440824 | 2014-09-01 | CN |
| (72) |
LI, Lixin , CN
LAU, Walter , CN
|
| (73) |
Birdie Biopharmaceuticals Inc. ,
Sertus Chambers
P.O. Box 2547
Cassia Court
Camana Bay, Grand Cayman,
KY
|
| (54) | ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |
| ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |